Search This Blog

Monday, October 5, 2026

HeartBeam Breakthrough Device Designation for at-home HeartBeam System for heart attack assessment

 

HeartBeam gets FDA Breakthrough Device Designation for at-home HeartBeam System for heart attack assessment

  • Breakthrough designation enables prioritized FDA review of the HeartBeam System for at-home heart attack assessment
  • Status positions the HeartBeam System for an expedited Medicare coverage pathway

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.